Bessemer Group’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$196K Sell
2,968
-39
-1% -$2.48K ﹤0.01% 1400
2025
Q4
$191K Buy
3,007
+427
+17% +$26.6K ﹤0.01% 1360
2025
Q3
$141K Buy
2,580
+2,063
+399% +$85K ﹤0.01% 1208
2025
Q2
$17K Sell
517
-41
-7% -$1.43K ﹤0.01% 1613
2025
Q1
$23K Buy
558
+7
+1% +$322 ﹤0.01% 1493
2024
Q4
$26K Sell
551
-1,381
-71% -$71.7K ﹤0.01% 1435
2024
Q3
$102K Buy
1,932
+716
+59% +$39.9K ﹤0.01% 1280
2024
Q2
$66K Sell
1,216
-44
-3% -$2.66K ﹤0.01% 1233
2024
Q1
$88K Buy
1,260
+1,255
+25,100% +$97.1K ﹤0.01% 1198
2023
Q4
$0 Hold
5
﹤0.01% 2172
2023
Q3
$0 Sell
5
-73
-94% -$2.43K ﹤0.01% 2195
2023
Q2
$3K Buy
+78
New +$2.89K ﹤0.01% 1933
2020
Q2
Sell
-2,900
Closed -$34K 1711
2020
Q1
$34K Buy
+2,900
New +$37K ﹤0.01% 1275
2016
Q1
Sell
-207
Closed -$2K 1509
2015
Q4
$2K Buy
+207
New +$2.03K ﹤0.01% 1497

Other funds holding CYTK